Discordant regulation of phenoloxidase and capsular polysaccharide in Cryptococcus neoformans

Journal of Medical and Veterinary Mycology

Volumn 34, Issue 4, 1996, Pages 289-291

  Jacobson, E S ^a   Compton, G M ^b  

^a McGuire Medical Group   (United States)

^b NONE

Author keywords

capsular polysaccharide; fungal pathogenesis; melanin; phenoloxidase; regulation; virulence factors

Indexed keywords

MONOPHENOL MONOOXYGENASE; POLYSACCHARIDE;

ARTICLE; CELL CYCLE S PHASE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; ENZYME REGULATION; FUNGUS CULTURE; FUNGUS GROWTH; NONHUMAN; VIRULENCE;

FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 0029813941     PISSN: 02681218     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219680000491     Document Type: Article

References (22)

1. Littman ML, Zimmerman LE. Cryptococcus. New York: Grune & Stratton, 1956.
2. Ro JY, Lee SS, Ayala AG. Advantage of Fontana-Masson stain in capsule-deficient cryptococcal infection. Arch Pathol Lab Med 1987; 111: 53-7.
3. Kwon-Chung KJ, Hill WB, Bennett JE. New special stain for histopathological diagnosis of cryptococcosis. J Clin Microbiol 1981; 13: 383-7.
4. Bulmer GS, Sans MD. Cryptococcus neoformans. III. Inhibition of phagocytosis. J Bacterial 1968; 95: 5-8.
5. Jacobson ES, Tinnell SB. Antioxidant function of fungal melanin. J Bacterial 1993; 175: 7102-4.
6. Wang Y, Casadevall A. Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect Immunol 1994; 62: 3004-7.
7. Bulmer GS, Sans MD, Gunn CM. Cryptococcus neoformans. I. Non-encapsulated mutants. J Bacterial 1967; 94: 1475-9.
8. Kwon-Chung KJ, Polacheck I, Popkin TJ. Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacterial 1982; 150: 1414-21.
9. Rhodes JC, Polacheck I, Kwon-Chung KJ. Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immunol 1982; 36: 1175-84.
10. Mekalanos JJ. Environmental signals controlling expression of virulence determinants in bacteria. J Bacterial 1992; 174: 1-7.
11. Kwon-Chung KJ. Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia 1976; 68: 821-33.
12. Jacobson ES, Ayers DJ, Harrell AC, Nicholas CC. Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J Bacterial 1982; 150: 1292-6.
13. Jacobson ES, Tingler MJ, Quynn PL. Effect of hypertonic solutes upon the polysaccharide capsule in Cryptococcus neoformans. Mycoses 1989; 32: 14-23.
14. Jacobson ES, Emery HS. Temperature regulation of the cryptococcal phenoloxidase. J Med Vet Mycol 1991; 29: 121-4.
15. Jacobson ES, Emery HS. Catecholamine uptake, melanization and oxygen toxicity in Cryptococcus neoformans. J Bacterial 1991; 173: 401-3.
16. Jacobson ES, Jenkins ND, Todd JM. Relationship between superoxide dismutase and melanin in a pathogenic fungus. Infect Immun 1994; 62: 4085-6.
17. Polacheck I, Hearing VJ, Kwon-Chung KJ. Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J Bacterial 1982; 150: 1212-20.
18. Vartivarian SE, Anaissie EJ, Cowart RE, et al. Regulation of cryptococcal capsular polysaccharide by iron. J Infect Dis 1993; 167: 186-90.
19. Nurudeen TA, Ahearn DG. Regulation of melanin production by Cryptococcus neoformans. J Clin Microbiol 1979; 10: 724-9.
20. Granger DL, Perfect JR, Durack DT. Virulence of Cryptococcus neoformans: regulation of capsule synthesis by carbon dioxide. J Clin Invest 1985; 76: 508-16.
21. Farhi F, Bulmer GS, Tacker JR. Cryptococcus neoformans. IV. The not-so-encapsulated yeast. Infect Immunol 1970; 1: 526-31.
22. Shaw CE, Kapica L. Production of diagnostic pigment by phenoloxidase activity of Cryptococcus neoformans. Appl Microbiol 1972; 24: 824-30.